Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ERENUMAB-AOOE Cause Injection site urticaria? 186 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 186 reports of Injection site urticaria have been filed in association with ERENUMAB-AOOE. This represents 0.4% of all adverse event reports for ERENUMAB-AOOE.

186
Reports of Injection site urticaria with ERENUMAB-AOOE
0.4%
of all ERENUMAB-AOOE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Injection site urticaria From ERENUMAB-AOOE?

Of the 186 reports, 1 (0.5%) required hospitalization, and 1 (0.5%) were considered life-threatening.

Is Injection site urticaria Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ERENUMAB-AOOE. However, 186 reports have been filed with the FAERS database.

What Other Side Effects Does ERENUMAB-AOOE Cause?

Accidental exposure to product (9,923) Device difficult to use (9,530) Wrong technique in product usage process (9,359) Drug dose omission by device (6,340) Migraine (4,290) Drug ineffective (3,813) Constipation (3,104) Product storage error (2,958) Headache (2,787) Injection site pain (2,715)

What Other Drugs Cause Injection site urticaria?

DUPILUMAB (3,104) ETANERCEPT (2,780) ADALIMUMAB (2,188) GLATIRAMER (1,091) TIRZEPATIDE (842) IXEKIZUMAB (652) EVOLOCUMAB (486) GALCANEZUMAB-GNLM (478) DULAGLUTIDE (450) HUMIRA (346)

Which ERENUMAB-AOOE Alternatives Have Lower Injection site urticaria Risk?

ERENUMAB-AOOE vs ERENUMAB\ERENUMAB-AOOE ERENUMAB-AOOE vs ERGOCALCIFEROL ERENUMAB-AOOE vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL ERENUMAB-AOOE vs ERIBULIN ERENUMAB-AOOE vs ERLOTINIB

Related Pages

ERENUMAB-AOOE Full Profile All Injection site urticaria Reports All Drugs Causing Injection site urticaria ERENUMAB-AOOE Demographics